Inicio › Cáncer de seno › California › Mountain View
Ensayos clínicos de Cáncer de seno en Mountain View, CA
26 estudios para Cáncer de seno buscan participantes en centros de Mountain View y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ReclutandoFase 3
- Stanford Women's Cancer Center, Palo Alto · A 5 mi de distancia
A Study of PHST001 in Advanced Solid Tumors
ReclutandoFase 1
- Stanford University School of Medicine, Palo Alto · A 5 mi de distancia
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
ReclutandoFase 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
ReclutandoFase 1/2
- Stanford Medicine Cancer Center, Stanford · A 5 mi de distancia
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
ReclutandoFase 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ReclutandoFase 1
- Stanford University Medical Center, Stanford · A 5 mi de distancia
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
ReclutandoFase 1
- Stanford University Medical Center, Stanford · A 5 mi de distancia
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- Stanford Cancer Center, Palo Alto · A 5 mi de distancia
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ReclutandoFase 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · A 5 mi de distancia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ReclutandoFase 3
- Stanford Women's Cancer Center, Palo Alto · A 5 mi de distancia
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
ReclutandoFase 1
- Stanford University Hospital, Stanford · A 5 mi de distancia
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ReclutandoFase 3
- Research Site, Palo Alto · A 5 mi de distancia
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
ReclutandoFase 2
- Stanford Cancer Institute, Palo Alto · A 5 mi de distancia
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
ReclutandoFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · A 5 mi de distancia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ReclutandoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · A 5 mi de distancia
- y 1 más
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
ReclutandoFase 2
- Stanford University, Stanford · A 5 mi de distancia
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
ReclutandoFase 2/3
- Local Institution - 0358, Stanford · A 5 mi de distancia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ReclutandoFase 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · A 5 mi de distancia
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
ReclutandoFase 1
- Stanford University Medical Center, Palo Alto · A 5 mi de distancia
Magnetic Resonance Imaging of Breast Cancer
ReclutandoSe aceptan voluntarios sanos
- Stanford University School of Medicine, Stanford · A 5 mi de distancia
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
ReclutandoEstudio observacional
- Stanford University School of Medicine, Stanford · A 5 mi de distancia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ReclutandoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · A 5 mi de distancia
- Stanford Cancer Institute Palo Alto, Palo Alto · A 5 mi de distancia
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
ReclutandoFase 1
- Stanford Cancer Institute, Stanford · A 5 mi de distancia
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Reclutando
- Stanford University, Stanford · A 5 mi de distancia
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
ReclutandoEstudio observacional
- Stanford Cancer Institute, Palo Alto · A 5 mi de distancia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Stanford · A 5 mi de distancia
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Mountain View
- Cáncer (todos los tipos)40 estudios
- Cáncer metastásico25 estudios
- Cáncer de pulmón de células no pequeñas21 estudios
- Leucemia mielógena aguda19 estudios
- Cáncer de ovario19 estudios
- Trastorno del espectro autista17 estudios
- Cáncer de pulmón17 estudios
- Cáncer de próstata15 estudios
- Fallo cardíaco15 estudios
- Autismo13 estudios
- Leucemia linfoblástica aguda13 estudios
- Cáncer del colon y del recto13 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.